Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5269437
Max Phase: Preclinical
Molecular Formula: C10H15NO4
Molecular Weight: 213.23
Associated Items:
ID: ALA5269437
Max Phase: Preclinical
Molecular Formula: C10H15NO4
Molecular Weight: 213.23
Associated Items:
Canonical SMILES: CC(C)[C@H](O)C12NC(=O)[C@H](C)[C@@H]1OC2=O
Standard InChI: InChI=1S/C10H15NO4/c1-4(2)6(12)10-7(15-9(10)14)5(3)8(13)11-10/h4-7,12H,1-3H3,(H,11,13)/t5-,6+,7+,10?/m1/s1
Standard InChI Key: FWPWHHUJACGNMZ-OEUIFBLYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 213.23 | Molecular Weight (Monoisotopic): 213.1001 | AlogP: -0.57 | #Rotatable Bonds: 2 |
Polar Surface Area: 75.63 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.38 | CX Basic pKa: | CX LogP: 0.09 | CX LogD: 0.09 |
Aromatic Rings: 0 | Heavy Atoms: 15 | QED Weighted: 0.60 | Np Likeness Score: 1.48 |
1. Song R, Qiao W, He J, Huang J, Luo Y, Yang T.. (2021) Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities., 64 (6.0): [PMID:33656892] [10.1021/acs.jmedchem.0c01640] |
Source(1):